Zim Laboratories to meet Tata Asset Management on July 3

0 min read     Updated on 01 Jul 2026, 06:36 AM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Zim Laboratories Ltd will hold a one-on-one meeting with Tata Asset Management Pvt. Ltd on July 3, 2026. The company confirmed that no unpublished price sensitive information will be shared during the interaction.

powered bylight_fuzz_icon
44413590

*this image is generated using AI for illustrative purposes only.

Zim Laboratories Ltd has scheduled a meeting with Tata Asset Management Pvt. Ltd to discuss business operations and performance. The interaction is set to take place on July 3, 2026, in a one-on-one format. The company stated that no unpublished price sensitive information would be shared during this session.

Meeting Details

The disclosure was made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The schedule is subject to change due to exigencies.

Day and Date Name of Investors/ Analysts/Conference Type of Meeting
Friday, 03 July 2026 Tata Asset Management Pvt. Ltd In person/Physical (One to One)

The meeting serves as a platform for the company to engage with investors and analysts without disclosing material non-public information.

Historical Stock Returns for Zim Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
-1.99%-8.74%+0.50%+66.62%-2.05%+1.33%

What specific aspects of Zim Laboratories' business operations are likely to be the focus of the discussion?

How might this engagement with Tata Asset Management influence investor sentiment toward Zim Laboratories?

Could this meeting signal potential future collaborations or strategic partnerships between the two entities?

Zim Laboratories passes all resolutions at 42nd AGM

1 min read     Updated on 30 Jun 2026, 01:15 AM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Zim Laboratories Limited conducted its 42nd Annual General Meeting on June 29, 2026, via video conferencing. Shareholders approved four resolutions, including the adoption of audited financial statements for FY26 and the re-appointment of Mr. Zulfiquar Kamal as director. The meeting also ratified the remuneration for cost auditors and approved a special resolution regarding director remuneration. All resolutions passed with over 99.99% of the valid votes cast.

powered bylight_fuzz_icon
44294700

*this image is generated using AI for illustrative purposes only.

Zim Laboratories Limited successfully concluded its 42nd Annual General Meeting on June 29, 2026, with shareholders approving all proposed resolutions. The meeting, conducted via video conferencing, saw the adoption of the audited financial statements for the financial year ended March 31, 2026, and the re-appointment of Mr. Zulfiquar Kamal as a director. Additionally, the members ratified the remuneration payable to cost auditors and approved a special resolution for managing director and whole-time director remuneration in case of profit inadequacy.

The proceedings were overseen by Chairman & Managing Director Dr. Anwar Siraj Daud. The Board of Directors appointed Roshni Jethani, Company Secretary in Practice, as the scrutinizer to oversee the electronic voting process. The remote e-voting period was open from June 26 to June 28, 2026, and the e-voting system remained available for 15 minutes post the conclusion of the AGM.

Voting Results

All four resolutions tabled at the meeting received approval from more than 99.99% of the valid votes cast. The detailed voting patterns for the resolutions are summarized below:

Resolution Description Votes For Votes Against % For % Against
Adoption of Financial Statements FY26 2,53,89,635 123 99.9995 0.0005
Re-appointment of Mr. Zulfiquar Kamal 2,53,89,585 173 99.9993 0.0007
Ratification of Cost Auditor Remuneration 2,53,89,585 173 99.9993 0.0007
Director Remuneration (Special Resolution) 2,53,89,635 123 99.9995 0.0005

Key Attendees and Proceedings

The meeting commenced at 11:30 a.m. IST and concluded at 1:23 p.m. Key attendees included Whole Time Directors Mr. Zulfiquar Kamal, Mr. Niraj Dhadiwal, and Mr. Prakash Sapkal, along with Independent Directors Mrs. Kavita Loya, Mr. Padmakar Joshi, Dr. Kamlesh Shende, and Mr. Ashok Bhatia. Mr. Shyam Mohan Patro, Chief Financial Officer, and Mr. Piyush Nikhade, Company Secretary, were also present.

The Chairman addressed the gathering on the company's performance during FY26 and outlined the future growth strategy. The Company Secretary confirmed that there were no qualifications or adverse remarks in the reports submitted by the Statutory Auditors and Secretarial Auditors. The statutory requirements for disclosing the proceedings under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, have been fulfilled.

Historical Stock Returns for Zim Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
-1.99%-8.74%+0.50%+66.62%-2.05%+1.33%

What specific growth strategies did the Chairman outline for the post-FY26 period?

How will the approval of director remuneration in case of profit inadequacy impact executive compensation structures?

What are the expected capital allocation priorities following the adoption of the FY26 financial statements?

More News on Zim Laboratories

Must Read Next

Earnings

Corporate Actions

Stocks

1 Year Returns:-2.05%